Exosome Cellular Uptake & Reporter Assays

OverviewServicesSamplesAdvantagesApplicationsCase StudyFAQs

Overview

At Creative BioMart Microbe, we provide comprehensive cellular uptake and reporter assay services purpose-built for microbial extracellular vesicles (mEVs), including bacterial outer membrane vesicles (OMVs), cytoplasmic membrane vesicles (CMVs) from Gram-positive bacteria, fungal EVs, and phage-derived vesicles. Our platform integrates fluorescent labeling, flow cytometry quantification, confocal microscopy imaging, live-cell time-lapse recording, and luciferase/GFP reporter assays into a single, standardized workflow that quantifies vesicle internalization efficiency, tracks intracellular trafficking, and validates functional cargo delivery to recipient cells.

Unlike generic cell assay CROs that apply mammalian exosome uptake protocols to microbial samples, we have optimized every labeling chemistry, cell model selection, and imaging parameter for the unique surface properties, size distributions, and membrane compositions of mEVs. From labeled vesicle preparation to quantitative uptake reports, clients receive validated internalization percentages, mechanistic pathway data, and functional delivery evidence that supports mechanism-of-action studies, product potency claims, and regulatory submissions for therapeutic, vaccine, and cosmetic applications. Contact us to discuss your specific cell model and uptake assay requirements.

Scientific schematic of integrated cellular uptake and reporter assay platform for microbial extracellular vesicles, showing fluorescent labeling, flow cytometry quantification, confocal microscopy imaging, and luciferase reporter validation modules.
Figure 1. Schematic overview of the integrated cellular uptake and reporter assay platform for microbial extracellular vesicles, spanning fluorescent vesicle labeling, flow cytometry uptake quantification, confocal microscopy internalization imaging, and functional cargo delivery reporter validation.

Services

Service Workflow

Commercial end-to-end service workflow diagram for cellular uptake and reporter assays showing seven stages from sample inquiry through vesicle labeling, cell model selection, uptake incubation, flow cytometry analysis, confocal imaging, reporter validation, and final report delivery.

Inquiry

Service Details

Isometric laboratory automation scene showing a robotic liquid handler dispensing PKH67-labeled vesicles into a 96-well plate next to a flow cytometer with scattered fluorescent dot plots showing uptake-positive cell populations.

Fluorescent Labeling & Uptake Quantification by Flow Cytometry

We label purified mEVs with lipophilic fluorescent dyes (PKH67, DiO, DiI) or membrane-impermeable near-infrared dyes and quantify uptake efficiency in recipient cell populations using high-throughput flow cytometry. Our standard assay panel includes dose-response curves (vesicle concentration 10⁷–10¹¹ particles/mL), time-course kinetics (15 min to 24 h), and competitive inhibition controls. Results include percentage of uptake-positive cells, mean fluorescence intensity (MFI), and uptake saturation parameters. For Gram-negative OMVs, we account for auto-fluorescence from LPS-associated pigments and apply spectral compensation. This assay is the primary quantitative readout for comparing uptake efficiency across different vesicle formulations, surface modifications, or target cell types.

3D product rendering of a confocal laser scanning microscope with z-stack imaging capability, heated live-cell chamber, and a digital display showing orthogonal xyz projections of internalized fluorescent vesicles within recipient cells.

Confocal Microscopy & Live-Cell Imaging of Internalization

We visualize mEV internalization and intracellular trafficking using confocal laser scanning microscopy (CLSM) with z-stack acquisition and orthogonal reconstruction. Fixed-cell assays provide high-resolution snapshots of vesicle localization (membrane-bound vs. cytosolic vs. perinuclear), while live-cell time-lapse imaging tracks internalization dynamics over minutes to hours in environmentally controlled chambers (37°C, 5% CO₂). Colocalization analysis with organelle markers (LysoTracker for lysosomes, ER-Tracker for endoplasmic reticulum, MitoTracker for mitochondria) reveals trafficking pathways and subcellular destination. Quantitative outputs include colocalization coefficients (Pearson, Manders), vesicle count per cell, and trafficking velocity.

Molecular close-up illustration showing a microbial vesicle fusing with a recipient cell membrane and releasing GFP-encoding mRNA into the cytoplasm, with subsequent GFP protein expression visible as green fluorescence within the cell nucleus and cytoplasm.

Reporter Assays for Functional Cargo Delivery

We validate functional delivery of vesicle cargo using dual-luciferase reporter systems, GFP/RFP expression assays, and CRISPR-Cas9 editing readouts. For RNA cargo validation, we load vesicles with firefly luciferase mRNA or siRNA targeting a constitutively expressed reporter gene and measure luminescence or fluorescence in recipient cells at 4–48 h post-incubation. For protein cargo validation, we quantify enzymatic activity of delivered beta-galactosidase or alkaline phosphatase. These assays provide direct evidence that internalized vesicles release bioactive cargo capable of modulating gene expression or protein function in recipient cells, bridging uptake quantification to biological outcome.

Biological cross-section illustration showing a recipient cell with labeled endocytosis pathways including clathrin-coated pits, caveolae, macropinocytosis, and lipid raft-mediated entry, with fluorescent microbial vesicles entering through distinct routes.

Mechanistic Uptake Pathway Analysis

We identify the endocytic pathways responsible for mEV internalization using pharmacological inhibitors and genetic knockdown approaches. Inhibitor panels target clathrin-mediated endocytosis (chlorpromazine, pitstop 2), caveolin-mediated uptake (filipin III, methyl-beta-cyclodextrin), macropinocytosis (EIPA, cytochalasin D), and lipid raft-dependent entry. Uptake efficiency is measured by flow cytometry in inhibitor-treated vs. vehicle-control cells, and pathway dominance is inferred from dose-dependent inhibition profiles. Genetic validation uses siRNA knockdown of clathrin heavy chain (CLTC), caveolin-1 (CAV1), or dynamin-2 (DNM2) in human cell lines. This service is essential for understanding how surface modifications alter uptake mechanisms.

Macroscopic biological scene showing a transwell insert with polarized intestinal epithelial monolayer, fluorescent microbial vesicles on the apical side, and transcytosed vesicles appearing on the basolateral side with immune cells in the lower chamber.

Exosome-Driven Cell Migration & Invasion Assays

We evaluate the functional impact of mEVs on recipient cell motility using wound-healing (scratch) assays and Transwell-based migration and invasion systems. Scratch assays track collective cell migration into a cell-free gap over time, while Transwell chambers quantify chemotactic migration through microporous membranes; Matrigel-coated inserts additionally measure invasive capacity through extracellular matrix. Migrated and invaded cells are quantified by fluorescence imaging or staining-based counting, and dose-response designs compare vesicle preparations, surface modifications, or cargo-loading strategies. These assays provide direct functional evidence linking vesicle uptake to phenotypic outcomes, supporting applications in cancer biology, tissue repair, and immune cell recruitment.

Service Specifications & QC Standards

Instrumentation & Capability

Fluorescent Labeling: PKH67, DiO, DiI, CFSE, near-IR dyes ( excitation/emission matched to flow cytometer lasers).
Flow Cytometry: BD FACSymphony A5 or equivalent, 5-laser configuration, high-throughput 96-well plate acquisition.
Confocal Microscopy: Leica SP8 or Zeiss LSM 900 with Airyscan, 405/488/561/633 nm laser lines, z-stack acquisition.
Live-Cell Imaging: Nikon Ti2-Eclipse with OKOLAB environmental chamber, 20× and 60× oil objectives, time-lapse acquisition.
Reporter Detection: SpectraMax iD3 plate reader (luminescence), Cytation 5 cell imaging multimode reader.
Transwell Assays: 6.5 mm inserts, 0.4 µm pore size, EVOM2 epithelial voltohmmeter for TEER measurement.
Cell Models: HEK293, Caco-2, HT-29, THP-1 (macrophage differentiation), hCMEC/D3, primary human keratinocytes.

Typical Data Range

Flow cytometry uptake: 5–80% uptake-positive cells (cell type and vesicle dependent).
Uptake saturation: typically 10⁹–10¹⁰ particles per 10⁵ cells.
Confocal colocalization: Pearson coefficient 0.3–0.8 (organelle dependent).
Live-cell trafficking: vesicle velocities 0.1–1.0 µm/s (cytoplasmic transport).
Luciferase reporter: signal-to-noise ratio ≥ 10-fold at 24 h; detection limit ≤ 10⁶ particles.
Transcytosis efficiency: 5–40% apical-to-basolateral transfer at 4–24 h (model dependent).

Turnaround Time

Project Type	Timeline
Flow cytometry uptake only	5–7 business days
Confocal imaging (fixed cells)	7–10 business days
Live-cell time-lapse imaging	10–14 business days
Luciferase reporter assay	7–10 business days
Uptake pathway analysis (inhibitors)	10–14 business days
Transcytosis assay	14–21 business days
Standard package (flow + confocal + reporter)	14–21 business days
Expedited analysis	+50% fee, 50% time reduction

Timeline may vary based on cell model availability, vesicle type, and assay complexity.

Deliverables

Flow cytometry: Uptake percentage, MFI histograms, dose-response curves, time-kinetics plots, FCS raw files.
Confocal imaging: High-resolution micrographs (z-stack, orthogonal views), colocalization analysis, vesicle count per cell.
Live-cell imaging: Time-lapse video files (AVI/MP4), tracking trajectories, velocity distributions.
Reporter assays: Luminescence/fluorescence values, dose-response curves, signal-to-noise ratios, raw plate reader data.
Pathway analysis: Inhibition dose-response curves, IC₅₀ values, pathway dominance ranking.
Transcytosis: TEER tracings, apical/basolateral fluorescence ratios, permeability coefficients.
Integrated report: Cross-assay summary with statistical analysis and QC flags.

Quality Control

Dye labeling efficiency: ≥ 95% vesicle association by NTA post-labeling; free dye removal by size-exclusion chromatography.
Cell viability: ≥ 90% viability at all tested vesicle concentrations (MTT or resazurin assay).
Inhibitor specificity: Confirmation of target pathway inhibition by western blot (clathrin, caveolin, dynamin).
Reporter controls: Non-cargo-loaded vesicles, lipofectamine positive control, mock-transfected negative control.
TEER validation: Monolayer integrity ≥ 400 Ω·cm² before transcytosis experiments; FITC-dextran P_app < 1 × 10⁻⁶ cm/s.
Instrument calibration: Daily fluorescence bead standardization for flow cytometry; argon-ion laser alignment for confocal.
Compliance checklist for minimal characterization requirements aligned with industry guidelines for extracellular vesicle studies.
Optional GxP-aligned assay validation and CQA trending analysis for lot-release documentation.

Sample Requirements

Required Information	Optional Information	Not Accepted
Sample type (OMVs, CMVs, fungal EVs, phage vesicles) Purified vesicle suspension Approximate particle concentration (NTA data preferred) Target cell type or tissue of interest Sample volume (minimum 100 µL for standard panel) Buffer composition and pH Storage conditions and shipping temperature	Prior uptake data or literature references Specific endocytosis pathway hypotheses Surface modification details (PEGylation, targeting ligands) Cargo type for reporter validation (RNA, protein, enzyme) Regulatory documentation requirements	Samples with visible aggregation or precipitation Samples in fixatives or organic solvents Samples without proper cold-chain documentation Intact bacterial/fungal cell cultures Contaminated or mixed samples Samples shipped at room temperature

Recommended Sample Quantity by Assay:

Assay	Minimum Volume	Recommended Volume
Flow cytometry uptake	50 µL	100 µL
Confocal imaging	50 µL	100 µL
Live-cell imaging	100 µL	200 µL
Reporter assay	100 µL	200 µL
Pathway analysis	200 µL	500 µL
Transcytosis assay	200 µL	500 µL
Standard package	300 µL	600 µL

Storage & Shipping: Ship purified vesicle suspensions on dry ice (–80°C) or wet ice (4°C) with cold-chain documentation. Avoid repeated freeze-thaw cycles. Recommended buffer: sterile PBS. For transcytosis assays, ship additional volume to account for apical chamber replenishment. Provide NTA-derived particle concentration if available.

Inquiry

Our Advantages

Microbial EV-Optimized Labeling Protocols: Our fluorescent labeling chemistries account for OMV lipid-A auto-fluorescence, fungal EV cell-wall debris interference, and CMV peptidoglycan-associated pigments that confound standard mammalian exosome labeling protocols. We validate labeling efficiency by NTA post-staining to ensure ≥95% vesicle association.
Integrated Uptake-to-Function Pipeline: We offer a continuum from quantitative uptake (flow cytometry) to subcellular trafficking (confocal) to functional cargo delivery (reporter assays) under standardized cell culture and vesicle dosing conditions. This eliminates inter-lab variability and provides mechanistic insight linking internalization to biological outcome.
Mechanistic Pathway Deconvolution: Our pharmacological inhibitor panel and genetic knockdown validation identify the dominant endocytic routes for each vesicle type and surface modification, enabling rational engineering of uptake efficiency for therapeutic and vaccine applications.
Barrier Penetration Expertise: We offer validated intestinal epithelial (Caco-2) and blood-brain barrier (hCMEC/D3) transcytosis models with TEER monitoring, providing preclinical data on in vivo bioavailability and CNS penetration potential.
Live-Cell Dynamics: Our environmental chamber-equipped confocal systems capture real-time vesicle trafficking, membrane fusion, and cargo release events, providing kinetic data that static imaging cannot reveal.

Applications

Vaccine adjuvant OMV uptake validation application showing central dendritic cell with internalized fluorescent OMVs surrounded by antigen presentation, T cell activation, and cytokine release functional modules.

OMV Vaccine Uptake & Immunogenicity Validation

Dendritic cell uptake assays and antigen presentation reporter systems validate OMV vaccine adjuvant potency and predict in vivo immunogenicity.

Therapeutic mEV targeted delivery optimization application showing left-to-right workflow from surface-engineered vesicles through receptor-mediated uptake to intracellular cargo release and therapeutic gene expression.

Therapeutic mEV Targeted Delivery Optimization

Uptake pathway analysis and reporter validation guide surface modification strategies to enhance target cell specificity and cargo delivery efficiency.

Probiotic mEV gut barrier transcytosis application showing a gut lumen scene with Lactobacillus-derived vesicles crossing intestinal epithelial tight junctions and reaching underlying immune cells in the lamina propria.

Probiotic mEV Gut Barrier Transcytosis

Caco-2 transcytosis assays quantify probiotic vesicle bioavailability and validate cross-barrier delivery of immunomodulatory cargo.

Cosmetic mEV skin penetration uptake application showing scale transition from macroscopic skin surface to microscopic vesicle uptake by keratinocytes and subsequent barrier-repair cargo delivery.

Cosmetic mEV Skin Penetration & Uptake

Primary keratinocyte uptake and transcytosis assays validate dermal penetration and intracellular cargo delivery for cosmetic vesicle actives.

Case Study

Case Study: Clathrin-Mediated Endocytosis of Botrytis cinerea Extracellular Vesicles into Plant Cells

Botrytis cinerea is a necrotrophic fungal pathogen that delivers small RNA cargo into host plant cells to suppress immunity genes. Researchers investigated the cellular uptake mechanism of B. cinerea extracellular vesicles (EVs) using a multi-modal imaging and genetic validation approach to define the entry pathway into Arabidopsis cells.

Confocal microscopy of fluorescently labeled EVs revealed colocalization with the plant clathrin light chain 1 (CLC1-GFP) marker at infection sites, with colocalization rates of 52% and 60% for CLC1-GFP and CHC2-YFP respectively, indicating clathrin-mediated endocytosis (CME) as the primary uptake route. Genetic validation using Arabidopsis CME pathway mutants (chc2-1 and ap2σ) showed 60–80% reduction in Bc-sRNA loading into host AGO1 and attenuated silencing of immunity genes (At-PRXIIF, At-MPK1/2, and At-WAK), confirming that functional cargo delivery depends on CME. This study demonstrates how integrated cellular uptake imaging and genetic pathway validation can elucidate the mechanistic basis of microbial EV host cell entry and functional cargo transfer.

Figure 2. Bc-sRNA loading into plant AGO1 and target gene suppression was reduced in CME mutants. (He, et al>. 2023)

FAQs

Q: Which fluorescent dye is best for labeling microbial EVs?

A: PKH67 (green) and DiO (green) are widely used for lipophilic membrane labeling and are compatible with most flow cytometers and confocal systems. For near-infrared detection or whole-animal imaging, DiR or Alexa Fluor 647-conjugated membranes are recommended. We validate labeling efficiency post-staining to ensure ≥95% vesicle association and remove free dye by size-exclusion chromatography.

Q: How do you distinguish surface-bound vesicles from truly internalized ones?

A: We use a combination of trypsin stripping (removes surface-bound but not internalized vesicles), acid wash (quenches surface fluorescence), and confocal z-stack analysis with orthogonal reconstruction to confirm intracellular localization. For live-cell imaging, trafficking dynamics (vesicle movement within cytoplasm) further confirm true internalization versus membrane adhesion.

Q: Can you use my own cell line for uptake assays?

A: Yes. We accommodate client-provided cell lines or recommend validated models from our inventory (HEK293, Caco-2, HT-29, THP-1, hCMEC/D3, primary keratinocytes). For custom cell lines, we require a material transfer agreement (MTA), mycoplasma-negative certification, and growth protocol documentation. Cell line authentication by STR profiling is available.

Q: What is the typical uptake efficiency for bacterial OMVs?

A: Uptake efficiency varies by cell type, vesicle concentration, and incubation time. For Gram-negative OMVs with mammalian cells, typical uptake-positive populations range from 20–60% at 10⁹–10¹⁰ particles per 10⁵ cells after 2–4 h. Fungal EVs often show lower uptake (10–30%) due to larger size and cell-wall debris. We provide dose-response and time-course curves to define optimal conditions for each vesicle-cell combination.

Q: Can reporter assays detect RNA cargo delivery specifically?

A: Yes. We offer firefly luciferase mRNA-loaded vesicles and measure luminescence in recipient cells at 4–24 h post-incubation as direct evidence of functional mRNA delivery and translation. For siRNA delivery, we use cells constitutively expressing GFP or luciferase and measure knockdown efficiency. These assays distinguish true cargo delivery from mere vesicle association.

Q: How does uptake pathway analysis guide vesicle engineering?

A: Identifying the dominant endocytic route (clathrin, caveolin, macropinocytosis) enables rational surface modification. For example, if clathrin-mediated endocytosis is dominant, adding clathrin-adaptor binding peptides can enhance uptake. If macropinocytosis dominates, osmotic or actin-modulating surface ligands may be more effective. Pathway data also predicts intracellular trafficking and lysosomal escape efficiency.

Q: What is the difference between uptake and transcytosis assays?

A: Uptake assays measure vesicle internalization into individual cells. Transcytosis assays measure vesicle passage across a polarized cell monolayer from apical to basolateral compartments, simulating barrier penetration (intestinal epithelium, blood-brain barrier). Transcytosis requires intact tight junctions (TEER ≥ 400 Ω·cm²) and provides bioavailability data that uptake assays alone cannot predict.

Q: Is your uptake assay service compatible with GxP requirements?

A: Our standard service is research-grade (R&D) with validated methods and full QC documentation. GxP-aligned analysis (IQ/OQ/PQ instrument qualification, method validation per ICH Q2(R1), audit trails, electronic signatures, and 21 CFR Part 11-compliant data management) is available as a custom service. Contact us to discuss your regulatory pathway requirements.

References:

He, B., et al>. (2023). Fungal small RNAs ride in extracellular vesicles to enter plant cells through clathrin-mediated endocytosis. Nature Communications, 14, 4383.

Services

Inquiry